Removal of methotrexate (MTX) in anuric patient: A case report.
Riferimento bibliografico:
(Abstracts: XXXIV Annual ESAO Congress, 5-8 September 2007, Krems – Austria) The International Journal of Artificial Organs / Vol. 30 / no. 8, Pag. 738 3 (P-29) 2007
(Abstracts: XXXIV Annual ESAO Congress, 5-8 September 2007, Krems – Austria) The International Journal of Artificial Organs / Vol. 30 / no. 8, Pag. 738 3 (P-29) 2007
Data pubblicazione:
Autori: Villani A,Ferrannini M, Staffolani E, Vischini G, Miani N, Condo S, Di Daniele N.
Methotrexate (MTX) is a nephrotoxic drug with a prevalent renal excretion. It is avoided in patients with renal failure. In literature there are few data about its dialysis removal. We describe a case of a 21-year-old female with anuria for ARF, affected by Burkitt limphoma, treated with MTX.
Visualizza il documento allegato 